SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 172 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $24,000 | -17.2% | 2,543 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $29,000 | -68.5% | 2,543 | -53.0% | 0.00% | -66.7% |
| Q3 2018 | $92,000 | +10.8% | 5,411 | -7.4% | 0.01% | +20.0% |
| Q2 2018 | $83,000 | +27.7% | 5,846 | +70.3% | 0.01% | +25.0% |
| Q1 2018 | $65,000 | -96.0% | 3,432 | -96.5% | 0.00% | -95.1% |
| Q4 2017 | $1,626,000 | +9.3% | 99,155 | +0.1% | 0.08% | +34.4% |
| Q3 2017 | $1,487,000 | – | 99,089 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |